For the quarter ended December 2023, The Beauty Health Company (SKIN) reported revenue of $96.8 million, down 1.4% over the same period last year. EPS came in at -$0.07, compared to $0.06 in the year-ago quarter.
Tuesday, March 12, 2024The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S (NVO), Tesla, Inc. (TSLA) a
(RTTNews) - Apple Inc. (AAPL) has announced that the iPhone users of European Union could now download apps directly from developer website, instead of through the tech giant's play store, following the pressure from EU regulators.
Brian Bolan is the aggressive growth stock strategist at Zacks Investment Research and he has two more stocks for your aggressive growth radar screen. This week he is taking a look at a couple of “A” stocks. Not only do these stoc
Tech stocks gained late Tuesday afternoon with the Technology Select Sector SPDR Fund (XLK) rising 1.9% and the SPDR S&P Semiconductor ETF (XSD) adding 0.7%.
Tech stocks were mixed Tuesday afternoon, with the Technology Select Sector SPDR Fund (XLK) rising 1.5% and the SPDR S&P Semiconductor ETF (XSD) down 0.3%.
The "Magnificent Seven" typically refers to the 1960 Western film, but today’s stock market investors recognize the term as the set of seven big tech stocks, namely Apple (AAPL), Microsoft (MSFT), Alphabet (GOOGL), Amazon (AMZN),
Bitcoin surged above the $72,000 mark on Monday, driven by supply challenges, hopes of the Fed cutting interest rates in June and robust demand for the digital asset since introduction of spot Bitcoin ETFs.
Enfusion, Inc. (ENFN) reported $46.49 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 14.7%. EPS of $0.04 for the same period compares to $0.03 a year ago.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings oft
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings oft
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings oft
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings oft
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings oft
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts ofte
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings oft
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts ofte